Total operating expenses Costs and Expenses Basis of Presentation and Significant Accounting Policies Significant Accounting Policies [Text Block] Document Quarterly Report Document Quarterly Report Statistical Measurement [Domain] Statistical Measurement [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Vested and exercisable (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Number Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Number Number of operating segments Number of Operating Segments Award Timing Predetermined Award Timing Predetermined [Flag] September 2025 Inducement Warrants September 2025 Inducement [Member] September 2025 Inducement 2026 (remaining) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Weighted Average Remaining Contractual Term, Outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Proceeds from issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs Proceeds from Issuance of Common Stock and Warrants Proceeds from Issuance of Common Stock and Warrants Entity File Number Entity File Number Additional Paid-In Capital Additional Paid-in Capital [Member] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Offering period Share-based Compensation Arrangement by Share-based Payment Award, Offering Period Share-based Compensation Arrangement by Share-based Payment Award, Offering Period Deposits and other assets Deposits Assets, Noncurrent Tabular List, Table Tabular List [Table Text Block] Licensing revenue Contract With Customer, Liability, New Contract Revenue Recognized Contract With Customer, Liability, New Contract Revenue Recognized Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Per share information: Earnings Per Share, Basic [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] Shares purchased for award (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award Non-PEO NEO Non-PEO NEO [Member] Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Recent Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Issuance of common stock under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Accounts payable Increase (Decrease) in Accounts Payable Interest income Interest Income (Expense), Nonoperating Milestones probable of being achieved Research And Development Arrangement, Milestones Probable Of Being Achieved Research And Development Arrangement, Milestones Probable Of Being Achieved Sale of Stock [Axis] Sale of Stock [Axis] Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] Name Trading Arrangement, Individual Name Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Warrants outstanding (in shares) Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Class of Warrant or Right, Outstanding Net loss per common share, basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Award Type [Domain] Award Type [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Equity Awards Adjustments Equity Awards Adjustments [Member] Total common stock reserved for future issuance (in shares) Shares of common stock reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Licensing Revenue Revenue from Contract with Customer [Text Block] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Commitments And Contingencies Disclosure [Line Items] Commitments And Contingencies Disclosure [Line Items] Commitments And Contingencies Disclosure [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Expected dividend yield (as a percent) Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate 2023 Amended and Restated Equity Incentive Plan Two Thousand And Twenty Three Amended And Restated Equity Incentive Plan [Member] Two Thousand And Twenty Three Amended And Restated Equity Incentive Plan Issuance of common stock under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Performance obligation, amount Revenue, Remaining Performance Obligation, Amount Issuance of common stock upon the exercise of warrants Stock Issued During Period, Value, Exercise Of Warrants Stock Issued During Period, Value, Exercise Of Warrants Adjustment to Compensation, Amount Adjustment to Compensation Amount MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Principles of Consolidation Consolidation, Policy [Policy Text Block] Non-cash stock-based compensation Share-Based Payment Arrangement, Noncash Expense Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Employee Stock Employee Stock [Member] Stock options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Clinical development Prepaid Research And Development Prepaid Research And Development Antidilutive Securities [Axis] Antidilutive Securities [Axis] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Total stock-based compensation Share-Based Payment Arrangement, Expense Common stock, shares authorized (in shares) Common Stock, Shares Authorized Current assets: Assets, Current [Abstract] Canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Statement of Income Location, Balance [Axis] Total Number of Shares (In Thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Cover [Abstract] Cover [Abstract] Maximum Maximum [Member] Minimum Minimum [Member] Upfront cash payment received Research And Development Arrangement, Cash Payment Received Research And Development Arrangement, Cash Payment Received Accounting Policies [Abstract] Accounting Policies [Abstract] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Company Selected Measure Name Company Selected Measure Name Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount March 2024 Registered Direct Offering March 2024 Registered Direct Offering [Member] March 2024 Registered Direct Offering Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Weighted Average Remaining Contractual Term, Vested and exercisable (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested And Exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested And Exercisable, Weighted Average Remaining Contractual Term Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Accounts payable Accounts Payable, Current Current and non-current operating lease liabilities Operating Lease, Liability Cash payments related to operating lease Operating Lease, Payments Proceeds from employee stock purchases Proceeds from Stock Plans Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] All Executive Categories All Executive Categories [Member] Common stock, $0.0001 par value; 350,000,000 shares authorized, 181,332,574 and 153,103,459 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Entity Shell Company Entity Shell Company Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Weighted-average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Segment Information Segment Reporting, Policy [Policy Text Block] Commitments and contingencies (Note 5) Commitments and Contingencies Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Operating lease, remaining term Lessee, Operating Lease, Remaining Lease Term Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Other Other Prepaid Expense, Current Entity Small Business Entity Small Business Name Measure Name Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Schedule of Allocated Stock-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Operating lease liabilities Operating Lease, Liability, Current Document Transition Report Document Transition Report Document Fiscal Period Focus Document Fiscal Period Focus Schedule of Common Stock Reserved for Future Issuance Common Stock Are Reserved For Future Issuance [Table Text Block] Common stock are reserved for future issuance. Underlying Securities Award Underlying Securities Amount GenFleet Therapeutics (Shanghai) Inc GenFleet Therapeutics (Shanghai) Inc [Member] GenFleet Therapeutics (Shanghai) Inc Eligible payment from collaboration for development and regulatory milestone achievement under collaborations agreement Collaborative Arrangement, Maximum Aggregate Development and Regulatory Milestone Payments Collaborative Arrangement, Maximum Aggregate Development and Regulatory Milestone Payments Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date Award Timing Method Award Timing Method [Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Award Type [Axis] Award Type [Axis] Balance Sheet Accounts Supplemental Balance Sheet Disclosures [Text Block] Total assets Assets Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Revenue from Contract with Customer [Abstract] Trading Symbol Trading Symbol Operating lease liabilities Increase (Decrease) in Operating Lease Liability Offering expenses included in accounts payable and accrued expenses and other current liabilities Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Entity Address, City or Town Entity Address, City or Town Document Type Document Type Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Name Outstanding Recovery, Individual Name Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Issuance of common stock upon the exercise of warrants (in shares) Stock Issued During Period, Shares, Exercise Of Warrants Stock Issued During Period, Shares, Exercise Of Warrants Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount All Individuals All Individuals [Member] Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] Statement of Income Location, Balance [Domain] Restricted stock units ("RSUs") Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Entity Emerging Growth Company Entity Emerging Growth Company Research and development Research and Development Expense (Excluding Acquired in Process Cost) Common stock warrants Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Stock options outstanding (in shares) Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Warrants to Acquire Shares of Common Stock Contract Indexed to Issuer's Equity [Text Block] Aggregate Intrinsic Value (In Thousands) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Aggregate Intrinsic Value [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Aggregate Intrinsic Value Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Purchase price of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Plan Name [Axis] Plan Name [Axis] Clinical development Contract Research Payable Contract Research Payable 2021 ESPP 2021 Employee Stock Purchase Plan [Member] 2021 Employee Stock Purchase Plan Current liabilities: Liabilities, Current [Abstract] PEO PEO [Member] October 2025 Inducement Warrants October 2025 Inducement [Member] October 2025 Inducement Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Net loss per common share, diluted (in dollars per share) Earnings Per Share, Diluted Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Title of 12(b) Security Title of 12(b) Security Aggregate Intrinsic Value, Vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Supplemental disclosure of non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Schedule of Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash, cash equivalents, restricted cash, and restricted cash equivalents at the beginning of period Cash, cash equivalents, restricted cash, and restricted cash equivalents at the end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs (in shares) Stock Issued During Period, Shares, Common Stock and Warrants Stock Issued During Period, Shares, Common Stock and Warrants Insurance Prepaid Insurance Number of shares of common stock sold (in shares) Sale of Stock, Number of Shares Issued in Transaction Sale of Stock [Domain] Sale of Stock [Domain] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Total non-operating income Nonoperating Income (Expense) Cash received during the period for interest Proceeds from Interest Received Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Liquidity Liquidation Basis of Accounting [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Non-cash lease expense Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities, Current RSUs outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Award Timing Disclosures [Line Items] Maximum amount eligible for milestones under collaborations agreement Collaborative Arrangement, Maximum Aggregate Sales Milestone Payments Collaborative Arrangement, Maximum Aggregate Sales Milestone Payments General and administrative General and Administrative Expense Unrecognized compensation cost, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Compensation and related benefits Employee-related Liabilities, Current Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Stockholders’ Equity Equity [Text Block] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Schedule of Assumptions for Option Grants Issued Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] General and administrative Selling, General and Administrative Expenses [Member] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Goodwill Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Expiration Date Trading Arrangement Expiration Date PEO Total Compensation Amount PEO Total Compensation Amount Other Other Accrued Liabilities, Current Equity Components [Axis] Equity Components [Axis] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Average vesting term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Future milestone payments received Research And Development Arrangement, Potential Milestone Payments To Be Received, Maximum Research And Development Arrangement, Potential Milestone Payments To Be Received, Maximum Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Number of reportable segments Number of Reportable Segments Entity Current Reporting Status Entity Current Reporting Status Issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs Stock Issued During Period, Value, Common Stock and Warrants Stock Issued During Period, Value, Common Stock and Warrants Upfront fee Collaborative Arrangement, Upfront Fee Collaborative Arrangement, Upfront Fee Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Loss from operations Operating Income (Loss) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Other Performance Measure, Amount Other Performance Measure, Amount Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Antidilutive Security, Excluded EPS Calculation [Table] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Total current liabilities Liabilities, Current Individual: Individual [Axis] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Event Type [Domain] Subsequent Event Type [Domain] Research and development Research and Development Expense [Member] Closing price of the company's common stock (in dollars per share) Closing Price Of Common Stock Closing price of common stock. Additional paid-in capital Additional Paid in Capital, Common Stock Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Shares reserved for future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Cash earnings contributed per year Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Adjustment to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Weighted average grant date fair value (in dollars per share) Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Plan Name [Domain] Plan Name [Domain] Weighted average recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Averages contractual term Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Antidilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Equity [Abstract] Equity [Abstract] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Shares of common stock authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Termination Date Trading Arrangement Termination Date Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Measure: Measure [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Operating lease, discount rate (as a percent) Operating Lease, Weighted Average Discount Rate, Percent Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Weighted-average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Cost of licensing revenue Cost of Product and Service Sold Exercised (in shares) Exercised (in shares) Class of Warrant or Right, Exercised Class of Warrant or Right, Exercised Restricted cash and cash equivalents Restricted Cash and Cash Equivalent, Current 2017 Equity Incentive Plan Two Thousand And Seventeen Equity Incentive Plan [Member] Two Thousand And Seventeen Equity Incentive Plan [Member] Milestone payment received Proceeds From Research And Development Arrangement, Milestone Payments Proceeds From Research And Development Arrangement, Milestone Payments Subsequent Events [Abstract] Subsequent Events [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Rent expense Operating Lease, Expense Entity Central Index Key Entity Central Index Key PEO Name PEO Name Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Weighted Average Exercise Price, Vested and exercisable (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested And Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested And Exercisable, Weighted Average Exercise Price Non-operating income: Nonoperating Income (Expense) [Abstract] Upfront fee and milestone payments Collaborative Arrangement, Upfront Fee And Milestone Payments Collaborative Arrangement, Upfront Fee And Milestone Payments Entity Tax Identification Number Entity Tax Identification Number Net proceeds of common stock Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Arrangement Duration Trading Arrangement Duration Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share At-The-Market Equity Offering Program (2026 ATM) At-The-Market Equity Offering Program (2026 ATM) [Member] At-The-Market Equity Offering Program (2026 ATM) Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted average exercise price (in dollars per share) Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Class of Warrant or Right, Outstanding [Roll Forward] Class of Warrant or Right, Outstanding [Roll Forward] Class of Warrant or Right, Outstanding [Roll Forward] Schedule of Warrant Activity Schedule Of Warrant Activity [Table Text Block] Schedule Of Warrant Activity Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount ASSETS Assets [Abstract] Subsequent Events Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Proceeds from warrant exercises Proceeds from Issuance of Warrants Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Security Exchange Name Security Exchange Name Canceled (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Stockholders’ equity: Equity, Attributable to Parent [Abstract] Total liabilities Liabilities Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses: Operating Expenses [Abstract] Operating lease liabilities, non-current Operating Lease, Liability, Noncurrent Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Commitments And Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Table] Commitments And Contingencies Disclosure Statement [Line Items] Statement [Line Items] Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Other Other Warrant Issues [Member] Other Warrant Issues [Member] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Schedule of RSU Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Proceeds from the exercise of common stock warrants Proceeds from Warrant Exercises Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Increase in number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Common Stock Common Stock [Member] RSUs vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Professional fees Prepaid Professional Services Prepaid Professional Services Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Potential milestone payments to be received Research And Development Arrangement, Potential Milestone Payments To Be Received Research And Development Arrangement, Potential Milestone Payments To Be Received Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Professional fees Accrued Professional Fees, Current Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period